Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does VELAGLUCERASE ALFA Cause Post procedural complication? 6 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 6 reports of Post procedural complication have been filed in association with VELAGLUCERASE ALFA (VPRIV). This represents 0.3% of all adverse event reports for VELAGLUCERASE ALFA.

6
Reports of Post procedural complication with VELAGLUCERASE ALFA
0.3%
of all VELAGLUCERASE ALFA reports
0
Deaths
6
Hospitalizations

How Dangerous Is Post procedural complication From VELAGLUCERASE ALFA?

Of the 6 reports, 6 (100.0%) required hospitalization.

Is Post procedural complication Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for VELAGLUCERASE ALFA. However, 6 reports have been filed with the FAERS database.

What Other Side Effects Does VELAGLUCERASE ALFA Cause?

Inappropriate schedule of product administration (197) Product dose omission issue (188) Covid-19 (163) Fatigue (136) Death (108) Fall (104) Pyrexia (101) Malaise (98) Weight increased (89) Headache (88)

What Other Drugs Cause Post procedural complication?

ADALIMUMAB (2,494) ETANERCEPT (318) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (244) UPADACITINIB (241) RISANKIZUMAB-RZAA (232) INFLIXIMAB (217) METHOTREXATE (188) TREPROSTINIL (174) HUMAN IMMUNOGLOBULIN G (159) PREDNISONE (157)

Which VELAGLUCERASE ALFA Alternatives Have Lower Post procedural complication Risk?

VELAGLUCERASE ALFA vs VELCADE VELAGLUCERASE ALFA vs VELETRI VELAGLUCERASE ALFA vs VELIPARIB VELAGLUCERASE ALFA vs VEMURAFENIB VELAGLUCERASE ALFA vs VENETOCLAX

Related Pages

VELAGLUCERASE ALFA Full Profile All Post procedural complication Reports All Drugs Causing Post procedural complication VELAGLUCERASE ALFA Demographics